首页> 美国卫生研究院文献>Integrative Cancer Therapies >Evaluation of Antiangiogenic Efficacy of Emilia sonchifolia (L.) DC on Tumor-Specific Neovessel Formation by Regulating MMPs VEGF and Proinflammatory Cytokines
【2h】

Evaluation of Antiangiogenic Efficacy of Emilia sonchifolia (L.) DC on Tumor-Specific Neovessel Formation by Regulating MMPs VEGF and Proinflammatory Cytokines

机译:通过调节MMPsVEGF和促炎细胞因子来评价艾米利亚son虫DC对肿瘤特异性新血管形成的抗血管生成功效

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Formation of new blood vessels from preexisting vasculature is an indispensable process in tumor initiation, invasion, and metastasis. Novel therapeutic approaches target endothelial cells involved in the process of angiogenesis, due to their genetic stability relative to the rapidly mutating drug-resistant cancer cells. In the present study, we investigated the effect of an active fraction from Emilia sonchifolia, belonging to the family Asteraceae, a plant well known for its anti-inflammatory and antitumor effects, on the inhibition of tumor-specific angiogenesis. Administration of the active fraction from E sonchifolia (AFES; 5 mg/kg, body weight, intraperitoneally) containing the major compound γ-humulene significantly inhibited B16F10 melanoma-induced capillary formation in C57BL/6 mice. The level of serum vascular endothelial growth factor and serum proinflammatory cytokines such as interleukin-1β, interleukin-6, tumor necrosis factor-α, and granulocyte-macrophage colony-stimulating factor were also reduced significantly. At the same time, administration of AFES significantly enhanced the production of antiangiogenic factors such as tissue inhibitor of matrix metalloproteinase-1. Dose-dependent reduction can be seen in the budding and expansion of microvessels from rat thoracic aorta by AFES treatment. Inhibition of the activation of proenzyme to active enzyme of matrix metalloproteinase along with a successful reduction of proliferation, invasion, and migration of human umbilical vein endothelial cells demonstrated the antiangiogenic effect of AFES in vitro. To date, no study has examined the antiangiogenic activity of this plant with already well-known anti-inflammatory and antitumor effects. Results obtained in the present study by using both in vivo and in vitro angiogenic models altogether proved the inhibitory effect of AFES on tumor-specific neovessel formation.
机译:由先前存在的脉管系统形成新血管是肿瘤起始,侵袭和转移中必不可少的过程。由于其相对于快速突变的耐药性癌细胞的遗传稳定性,新的治疗方法靶向血管生成过程中涉及的内皮细胞。在本研究中,我们调查了艾美莉亚活性成分(其菊苣科植物,以其抗炎和抗肿瘤作用而闻名)对抑制肿瘤特异性血管生成的作用。含有主要化合物γ-腐殖质的肠球菌大肠杆菌活性成分(AFES; 5 mg / kg,体重,腹膜内)的给药显着抑制了C57BL / 6小鼠中B16F10黑色素瘤诱导的毛细血管形成。血清血管内皮生长因子和血清促炎细胞因子如白细胞介素-1β,白细胞介素-6,肿瘤坏死因子-α和粒细胞-巨噬细胞集落刺激因子的水平也显着降低。同时,AFES的施用显着增强了抗血管生成因子的产生,例如基质金属蛋白酶-1的组织抑制剂。通过AFES处理,可以观察到大鼠胸主动脉微血管的出芽和扩增中剂量依赖性降低。抑制原酶对基质金属蛋白酶活性酶的激活以及成功减少人脐静脉内皮细胞的增殖,侵袭和迁移证明了AFES在体外具有抗血管生成作用。迄今为止,尚无研究检验该植物具有已知的抗炎和抗肿瘤作用的抗血管生成活性。通过使用体内和体外血管生成模型在本研究中获得的结果完全证明了AFES对肿瘤特异性新血管形成的抑制作用。

著录项

相似文献

  • 外文文献
  • 中文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号